PMC4540113_01
Multiple intraperitoneal dissemination (A and B) and intrapelvic lymph node metastases (C) were observed before treatment (arrows). After eight cycles of weekly paclitaxel plus bevacizumab therapy, the antitumor effect was evaluated as a complete response (D-F).
ott-8-2097Fig1.jpg
PMC4540113_01_ott-8-2097Fig1.jpg
f1-ott-8-2097
Computed tomography (CT) at our hospital revealed that no evidence of ascites, multiple intraperitoneal dissemination, or intrapelvic lymph node metastases was present (Figure 1). The antitumor effect was evaluated as a complete response (Figure 1).